Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease

被引：21
|
作者：
Omran, Jad [1 ]
Al-Dadah, Ashraf [3 ]
Dellsperger, Kevin C. [2 ,3 ]
机构：
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO 65212 USA
[2] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA
[3] Univ Missouri, Sch Med, Div Cardiovasc Med, Columbia, MO 65212 USA
来源：
CARDIORENAL MEDICINE | 2013年 / 3卷 / 03期
关键词：
Dyslipidemia; Oxidized low-density lipoprotein; Chronic kidney disease; End-stage renal disease; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; EXPANDED CLINICAL-EVALUATION; RENAL-TRANSPLANT RECIPIENTS; TYPE-2; DIABETES-MELLITUS; EXTENDED-RELEASE NIACIN; ESTER TRANSFER PROTEIN; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PRIMARY-PREVENTION;
D O I：
10.1159/000351985
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码：165 / 177
页数：13
相关论文
共 50 条
  • [1] Dyslipidemia in chronic kidney disease and end-stage renal disease: A review
    Appel, GB
    Appel, AS
    DIALYSIS & TRANSPLANTATION, 2004, 33 (11) : 714 - +
  • [2] Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease
    Mona Khurana
    Douglas M. Silverstein
    Pediatric Nephrology, 2015, 30 : 2073 - 2084
  • [3] Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease
    Khurana, Mona
    Silverstein, Douglas M.
    PEDIATRIC NEPHROLOGY, 2015, 30 (12) : 2073 - 2084
  • [4] NEPHRECTOMY POLYCYSTIC KIDNEY DISEASE PATIENTS WITH END-STAGE CHRONIC KIDNEY DISEASE
    Dymkov, Ivan
    Perlin, Dmitriy
    Alexandrov, Ilya
    Bizhiev, Shamil
    TRANSPLANT INTERNATIONAL, 2019, 32 : 332 - 332
  • [5] Pain management in patients with chronic kidney disease and end-stage kidney disease
    Roy, Payel J.
    Weltman, Melanie
    Dember, Laura M.
    Liebschutz, Jane
    Jhamb, Manisha
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (06): : 671 - 680
  • [6] Pulmonary hypertension in patients with chronic and end-stage kidney disease
    Sise, Meghan E.
    Courtwright, Andrew M.
    Channick, Richard N.
    KIDNEY INTERNATIONAL, 2013, 84 (04) : 682 - 692
  • [7] IS A NEPHRECTOMY POLYCYSTIC KIDNEY DISEASE NECESSARY FOR PATIENTS WITH END-STAGE CHRONIC KIDNEY DISEASE?
    Perlin, Dmitriy
    Dymkov, Ivan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 337 - 337
  • [8] Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis
    Plesner, Louis L.
    Warming, Peder E.
    Nielsen, Ture L.
    Dalsgaard, Morten
    Schou, Morten
    Host, Ulla
    Rydahl, Casper
    Brandi, Lisbet
    Kober, Lars
    Vestbo, Jorgen
    Iversen, Kasper
    HEMODIALYSIS INTERNATIONAL, 2016, 20 (01) : 68 - 77
  • [9] Sleeping disorders in patients with end-stage renal disease and chronic kidney disease
    De Santo, Rosa Maria
    Bartiromo, Marilu
    Cesare, Maria Concetta
    De Santo, Natale G.
    Cirillo, Massimo
    JOURNAL OF RENAL NUTRITION, 2006, 16 (03) : 224 - 228
  • [10] Vascular calcification progression in patients with end-stage chronic kidney disease
    San Norberto, Enrique M.
    Revilla, Alvaro
    Fernandez-Urbon, Ana
    Gomez-Giralda, Beatriz
    Taylor, James H.
    Vaquero, Carlos
    INTERNATIONAL ANGIOLOGY, 2021, 40 (06) : 528 - 536
12345